Fusion Pharmaceuticals
collaboration agreement with option to commercialize in solely funds unless fusion opts in | Fusion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
19 of 33
Related slides by other companies
Certara
Investor Day
December 2021
platform approach to quantitative systems pharmacology i | Certara
AN2 Therapeutics
Investor Presentation
March 2025
advancing novel therapies using our boron chemistry platform gay | AN2 Therapeutics
Adobe
Investor Day
October 2022
| Adobe
AstraZeneca
Results
November 2023
building the pipeline of the future delivering sustainable industry leading growth cell therapy gene therapy cell novel therapies therapy area leadership broad pipeline and focused investment to deliver transformative new medicines | AstraZeneca
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
IPO
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights